Latest filing published 11 Aug 2025 for Jazz Pharmaceuticals plc.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Anne ORiordan: trading record in brief
Anne ORiordan (senior executive) discloses dealings in Jazz Pharmaceuticals plc to SEC (Form 4). The record holds 14 filings, for trades running from 28 February 2019 to 8 August 2025.
The open-market record consists of 4 sales worth €386k, with no purchase. Other entries cover 10 share grants.
The latest filing, published on 11 August 2025, reports a share grant of €172k in Jazz Pharmaceuticals plc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Anne ORiordan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,507 shares0Ordinary SharesSEC:0001765581-25-000084:0
- 3,731 shares0Ordinary SharesSEC:0001765581-24-000076:0
- 3,075 shares0Ordinary SharesSEC:0001765581-23-000098:0
- 2,561 shares0Ordinary SharesSEC:0001765581-22-000094:0
- 457 shares@ US$148.927.8% of flowOrdinary SharesSEC:0001765581-22-000051:0
- 2,246 shares0Ordinary SharesSEC:0001765581-21-000079:0
6 of 6 declarations
